Bernd Schmidt
Chief Technical Officer @Sensorion
Signup · Get unlimited contacts
WORK HISTORY
Chief Technical Officer @Sensorion
CTO | Executive Committee | Enterprise Technical Operations, CMC, Manufacturing & SupplyLeading corporate technical strategy and execution for a clinical-stage gene therapy and small molecule company, with COO-level accountability across product development, global manufacturing, quality, and supply.Key contributions:• End-to-end accountability for CMC, manufacturing strategy, clinical supply, and quality operations.• Driving organisational evolution from R&D-centric to commercial-ready, scalable operations.• Building global partnerships, CDMO networks, and supply resilience for future launch needs.• Representing the company with Board, investors, regulators, partners, and strategic collaborators.• Embedding a high-performance culture aligned with innovation, compliance, and business growth.Keywords: CTO, COO-level, Technical Operations, CMC Strategy, Commercial Readiness, CGT Manufacturing, Global Supply, Executive Leadership.
EDUCATION
Friedrich-Alexander University (Erlangen, Germany)
Dipl-Ing. Univ. ('Advanced MSc'; First Class), Chemical Engineering
ABOUT BERND SCHMIDT
Biopharma executive with enterprise-level leadership experience in building and scaling organisations delivering advanced therapies. I operate at CTO/COO-level with enterprise accountability for technical operations, including CMC strategy, product development, manufacturing, quality and supply. With over 15 years of global leadership across pharmaceuticals and advanced therapies, I bring a unique blend of strategic, operational, and scientific expertise to building and scaling organisations that deliver life-changing medicines.As Chief Technical Officer at Sensorion and former senior leader at Quell Therapeutics and GSK, I have led enterprise-wide transformations, integrating technical innovation, business growth, and operational excellence across the full product lifecycle from discovery to commercial supply.My experience spans small molecules, biologics, and cell & gene therapies, and includes:• Building and scaling new development and manufacturing capabilities from concept to commercial readiness• Leading global, cross-functional teams of more than 100 FTE with multimillion-pound budgets• Delivering complex technical and organisational transformations that accelerated portfolio delivery and reduced time-to-market• Partnering with Boards, investors, and regulators (FDA, EMA, MHRA, PMDA) to enable clinical and commercial success• Overseeing facilities and investments exceeding £100m while ensuring compliance, quality, and resilienceRecognised for my analytical, financial, and people-focused leadership, I combine scientific rigour with commercial pragmatism and a consistent record of execution under pressure.Focus: enterprise leadership | business transformation | global manufacturing & supply | strategy & growth | cell & gene therapy | operational excellence | team and culture development
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.